CYCLERION THERAPEUTICS INC's ticker is CYCN and the CUSIP is 23255M105. A total of 44 filers reported holding CYCLERION THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $31 | – | 48 | +4700.0% | 0.00% | – |
| Q3 2022 | $0 | – | 1 | -96.6% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 29 | -98.8% | 0.00% | – |
| Q1 2022 | $3,000 | +200.0% | 2,471 | +429.1% | 0.00% | – |
| Q4 2021 | $1,000 | -50.0% | 467 | -10.5% | 0.00% | – |
| Q3 2021 | $2,000 | -91.3% | 522 | -91.3% | 0.00% | – |
| Q2 2021 | $23,000 | -74.4% | 6,015 | -81.5% | 0.00% | – |
| Q1 2021 | $90,000 | +87.5% | 32,502 | +105.3% | 0.00% | – |
| Q4 2020 | $48,000 | -21.3% | 15,835 | +57.2% | 0.00% | – |
| Q3 2020 | $61,000 | -34.4% | 10,070 | -35.6% | 0.00% | – |
| Q2 2020 | $93,000 | +232.1% | 15,639 | +46.9% | 0.00% | – |
| Q1 2020 | $28,000 | -17.6% | 10,645 | -15.4% | 0.00% | – |
| Q4 2019 | $34,000 | -85.6% | 12,583 | -35.4% | 0.00% | – |
| Q3 2019 | $236,000 | -36.6% | 19,476 | -40.1% | 0.00% | – |
| Q2 2019 | $372,000 | – | 32,516 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 552 | $2 | 0.00% |